You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Citation Tools

Article menu

Download PDFPDF

XML
Commentary
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pai SI, Faivre S, Licitra L, et al
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)
Journal for ImmunoTherapy of Cancer 2019;7:96. doi: 10.1186/s40425-019-0578-0